Dedicated to the care and cure of people with Lou Gehrig's Disease
Big Boost in Drug Discovery
Using a new, stem-cell based, drug-screening technology that could reinvent and greatly reduce the cost of developing pharmaceuticals, researchers at the Harvard Stem ... read more
FDA Convenes ALS Public Hearing February 25
The Food and Drug Administration (FDA) will hold a public hearing on February 25, 2013, to allow patients, caregivers, advocates, health care providers, academia, ... read more
Biogen Idec's EMPOWER study fails to demonstrate efficacy
Biogen Idec announced today that the results of their randomized, double-blind, placebo-controlled Phase 3 trial of dexpramipexol in people living with ALS, known as the ... read more
Hope for ALS Patients
The mice in Prof. Esther Priel’s Ben-Gurion University lab in southern Israel live only four months. That’s because they are genetically engineered to ... read more
ALS Association/NEALS PALS Webinar
Upper Motor Neuron Research WebinarJuly 2, 20123:00 PMHiroshi Mitsumoto, MDNazem Atassi, MD, MMSc Contact: alstrials@partners.org Hiroshi Mitsumoto, MD, (Columbia ... read more
Blocking metabolic protein improves movement in animals with ALS
Findings suggest energy deficits may contribute to neurodegenerative disorders Washington, DC — Turning off a protein that helps cells balance energy ... read more
Phase II Trial of ALS Drug Yields Positive Results
CK-201357 - an experimental drug developed by the South San Francisco biotechnology company, Cytokinetics - is expected to increase muscle sensitivity to calcium and ... read more
Disappointing Results of Olesoxime Clinical Trial Announced
The drug, Olesoxime, in Phase III of clinical testing was recently found to be ineffective in patients. Trophos SA, the company conducting the study in Europe, was ... read more
Researchers at Northwestern University Identify Another Protein Involved in ALS
A team of 23 researchers in the Davee Department of Neurology and Clinical Neurosciences at Northwestern's Feinberg School of Medicine suggest that the protein, ... read more
May is ALS Awareness Month
Amyotrophic Lateral Sclerosis (ALS), more commonly referred to as Lou Gehrig's disease, is a neuromuscular disease that causes damage to the nerve cells ... read more
Upcoming Ceftriaxone Webinar on May 5th
On Thursday, May 5th 2011 at 3:00 p.m. EST there will be an informational web seminar for people with ALS interested in learning about the clinical trial of ... read more
$1 Million to Inventor of Tracker for A.L.S.
BOSTON — Tracking the inexorable advance of amyotrophic lateral sclerosis, the deadly neuromuscular ailment better known as Lou Gehrig’s disease or ... read more
Researchers at University of Pennsylvania find possible genetic link to Lou Gehrig's disease
Uncovering a rare clue to a baffling disease, scientists at the University of Pennsylvania have discovered a genetic stutter that may influence the risk of developing ... read more
Additional $3 Million for the ALS Registry
Congress passed legislation late yesterday to provide an additional $3 million in funding for the ALS registry at the Centers for Disease Control and Prevention. The ... read more
One-Man Gridlock: Meet Tom Coburn, Senate's 'Dr. No'
WASHINGTON -- On Tuesday afternoon, when most senators were preparing to leave Washington for the holiday recess, Tom Coburn was declaring his intention to stick ... read more
©2012 ALS Hope Foundation
1333 Race Street, Suite 202 • P.O. Box 40777 • Philadelphia, PA 19107
Foundation Office: (215) 568-2426 •
MDA/ALS Center of Hope: (267) 507-2585
Southeastern Pennsylvania United Way Donor Choice Number: 13004
Delaware United Way Donor Choice Number: 12703
Sitemap